ASX:ACR

Acrux Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume4,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive ACR News and Ratings via Email

Sign-up to receive the latest news and ratings for Acrux and its competitors with MarketBeat's FREE daily newsletter.

About Acrux

Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.

ASX Health Stocks: HeraMed jumps 11pc on survey results, while Acrux seeks FDA approval for acne gel
September 12, 2021 | msn.com

Acrux Limited (ACR.AX)
August 28, 2021 | uk.finance.yahoo.com

Is Acrux (ASX:ACR) In A Good Position To Invest In Growth?
August 25, 2021 | finance.yahoo.com

ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
July 27, 2021 | msn.com

Arc'Teryx's new lightweight mountaineering boot won't weigh you down as you scale those alpine peaks
July 24, 2021 | msn.com

Suda Pharma pops 44pc on cap raise; Acrux and other biotechs whet investor appetites
June 22, 2021 | msn.com

Acrux shares gain after FDA approves its toenail fungus treatment
June 22, 2021 | msn.com

10 at 10: These ASX stocks are in the upper echelon of performers this morning
June 21, 2021 | msn.com

Why the Acrux (ASX:ACR) share price is rocketing 39% higher today
June 21, 2021 | fool.com.au

How to navigate by the stars: the basics of celestial navigation
May 24, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:ACR
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.acrux.com.au
Phone: +61-3-83790100
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1.34 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 1.57
Book Value: A$0.07 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 12.10
Current Ratio: 6.72
Quick Ratio: 6.66

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Acrux.

4.7 Community Rank

Outperform Votes
Acrux has received 94 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Acrux has received 42 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Acrux has received 69.12% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Acrux and other stocks. Vote “Outperform” if you believe ACR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Acrux does not currently pay a dividend.
Dividend Growth
Acrux does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Acrux insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Acrux (ASX:ACR) Frequently Asked Questions

What stocks does MarketBeat like better than Acrux?: Wall Street analysts have given Acrux a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acrux wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How were Acrux's earnings last quarter?: Acrux Limited (ASX:ACR) announced its earnings results on Thursday, February, 21st. The company reported ($0.02) earnings per share for the quarter.
View Acrux's earnings history.
Who are Acrux's key executives?: Acrux's management team includes the following people:
Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus, CEO, MD & Exec. Director (Age 55, Pay $510.01k)
Ms. Joanna Johnson B.E., BEc, ICAA, CFO & Company Sec.
Who are some of Acrux's key competitors?: Some companies that are related to Acrux include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR), Annovis Bio (ANVS) and Arno Therapeutics (ARNI).
View all of ACR's competitors.
What other stocks do shareholders of Acrux own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Acrux investors own include Australia and New Zealand Banking Group (ANZ), Lynas Rare Earths (LYC), Altium (ALU), Atlas Iron (AGO), Hugo Boss (BOSS), BHP Group (BHP), Beacon Roofing Supply (BECN), Billabong International (BBG), Abraxas Petroleum (AXAS) and Ausdrill (ASL).
What is Acrux's stock symbol?: Acrux trades on the ASX under the ticker symbol "ACR."
How much money does Acrux make?: Acrux has a market capitalization of $0.00 and generates $1.34 million in revenue each year.
How many employees does Acrux have?: Acrux employs 2,018 workers across the globe.
What is Acrux's official website?: The official website for Acrux is www.acrux.com.au.
Where are Acrux's headquarters?: Acrux is headquartered at 103-113 Stanley St, MELBOURNE, VIC 3003, Australia.
How can I contact Acrux?: Acrux's mailing address is 103-113 Stanley St, MELBOURNE, VIC 3003, Australia. The company can be reached via phone at +61-3-83790100.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Acrux Stock Forecast, Price & News

About Acrux

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Acrux (ASX:ACR) Frequently Asked Questions

What stocks does MarketBeat like better than Acrux?

How were Acrux's earnings last quarter?

Who are Acrux's key executives?

Who are some of Acrux's key competitors?

What other stocks do shareholders of Acrux own?

What is Acrux's stock symbol?

How much money does Acrux make?

How many employees does Acrux have?

What is Acrux's official website?

Where are Acrux's headquarters?

How can I contact Acrux?